drugset / Trial / NCT00148733

CHIZAP: Community- and Health Facility-Based Intervention With Zinc as Adjuvant Therapy for Childhood Pneumonia

NCT00148733

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of the study described is to measure the degree with which zinc given as adjunct therapy to standard antibiotic treatment during childhood pneumonia reduces the risk of treatment failure and the duration of the illness.

Timeline

Start
2004-01
Primary completion
2008-01
Completion
2008-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Zinc Sulfate Unknown 10 mg Oral
Subject Zinc Sulfate Unknown 20 mg Oral

Indications